MAIA Biotechnology Reports Third Quarter 2022 Financial Resu

Conducted an oral presentation covering the novel THIO platform at the XIV International Round Table on Nucleosides, Nucleotides, and Nucleic AcidsPresented the design of its ongoing Phase 2 THIO-101 trial at ESMO 2022Presented results of a study of THIO in hepatocellular carcinoma in vitro and in vivo models at the...

Related Keywords

Australia , United States , Paris , France General , France , Stockholm , Sweden , Spain , Barcelona , Comunidad Autonoma De Cataluna , Australian , American , Stephanie Carrington , Joseph Mcguire , Development Rd Expenses , International Round Table On Nucleosides , Biotechnology Inc , European Society For Medical Oncology , Round Table , Nucleic Acids , Triple Meeting , Molecular Targets , Cancer Therapeutics , Longevity Stock Index , Vlad Vitoc , Chief Executive , Design Presented , Non Small Cell Lung Cancer , European Society , Medical Oncology , Triple Meeting Symposium , Stock Index Listing ,